Barclays
MR

Barclays’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Barclays’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-216,442
Closed -$5.84M – 6773
2015
Q4 		$5.84M Sell
216,442
-11,628
-5% -$300K 0.01% 1214
2015
Q3 		$4.79M Buy
228,070
+77,312
+51% +$1.97M 0.01% 1401
2015
Q2 		$4.22M Buy
150,758
+31,059
+26% +$905K ﹤0.01% 1629
2015
Q1 		$3.23M Sell
119,699
-15,750
-12% -$434K ﹤0.01% 1905
2014
Q4 		$3.52M Sell
135,449
-120,290
-47% -$3.52M ﹤0.01% 2003
2014
Q3 		$7.67M Sell
255,739
-212,573
-45% -$6.58M 0.01% 1395
2014
Q2 		$14.5M Buy
468,312
+73,311
+19% +$2.33M 0.02% 906
2014
Q1 		$12.6M Buy
395,001
+258,294
+189% +$9.04M 0.01% 986
2013
Q4 		$4.92M Buy
136,707
+65,149
+91% +$2.53M 0.01% 1840
2013
Q3 		$2.72M Buy
71,558
+33,345
+87% +$1.34M ﹤0.01% 2241
2013
Q2 		$1.43M Buy
+38,213
New +$1.51M ﹤0.01% 2925

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Barclays's MR Position: Q1 2016 in Review

Barclays sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 216,442 shares — an estimated $5.84M sold.

Barclays first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $14.5M in Q2 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Barclays reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Barclays sold 216,442 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $5.84M.
  • Barclays first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Barclays's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $14.5M in Q2 2014.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.